Phase 1-11 Study of MEK 162 for Children with Progressive or Recurrent Cancer and A Phase 11 Study of Children with Low- Grade Gliomas and Other Ras/ RAF/MAP Pathway Activated Tumors

Grant

Date/time Interval

  • May 30, 2017 - May 29, 2020
  • Awarded By

    Total Award Amount

  • 15023.00
  • Direct Costs

  • 11046.00
  • Sponsor Award Id

  • Contributor

  • Alva, Elizabeth   Principal Investigator  
  • Aye, Jamie   Investigator  
  • Friedman M.D., Gregory   Investigator  
  • Metrock, Laura   Investigator